Loading…
Loading grant details…
| Funder | NATIONAL HEART, LUNG, AND BLOOD INSTITUTE |
|---|---|
| Recipient Organization | University of Massachusetts Med Sch Worcester |
| Country | United States |
| Start Date | Jul 01, 2023 |
| End Date | Aug 31, 2028 |
| Duration | 1,888 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10735582 |
Project Summary/Abstract – Technology Core The goal of the Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders (HLBS) is to develop and optimize novel point of care technologies (POC) and home-based technologies to improve the diagnosis and treatment of HLBS disorders, especially those targeted for low
resource settings. HLBS disorders collectively represent the single greatest source of morbidity and mortality in the US, and they disproportionately affect minoritized and underserved populations. New POC and home-based technologies are critical enablers of the ongoing transformation of healthcare, which is moving out from
specialized inpatient testing facilities into the clinic and the home. CAPCaT was originally based on the highly successful medical product incubator, the Massachusetts Medical Device Development Center (M2D2), at the University of Massachusetts (UMass) Lowell and UMass Chan campuses. UMass Lowell has strengths in
engineering and business, while the Worcester campus houses the UMass Chan Medical School, the first and only public academic health system in the Commonwealth of Massachusetts. Over the past five years, CAPCaT has conducted four national calls for applications and from 441 applicants has selected, awarded, monitored,
and comprehensively supported 23 HLBS POC innovations. CAPCaT awardees have raised over $43M in funding, refined/developed new products, generated 9 new intellectual properties, and brought new technologies to market. In this competitive renewal, the Technology Core of CAPCaT will continue to issue broad-reaching
calls for applications and will select and support new meritorious projects focusing on later-stage POC and home- based technologies from across the HLBS space. Selection will be based on performance and potential for clinical impact, likelihood of implementation and addressing an HLBS health disparity. CAPCaT’s Technology
Core will support selected projects utilizing a strong collection of existing resources at UMass Lowell and UMass Chan to help further develop and refine later-stage prototypes to the point of validation and user-testing.
University of Massachusetts Med Sch Worcester
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant